S5665 Rapidly Progressive Splanchnic Thrombosis in Essential Thrombocytosis: When Anticoagulation Isn’t Enough

Introduction: Splanchnic venous thrombosis (SVT) includes thrombosis of splenic, mesenteric, portal, and hepatic veins. Portal (PV) and mesenteric veins are most commonly affected, whereas hepatic vein involvement, known as Budd-Chiari syndrome (BCS), is less common. We present a complex case of extensive SVT requiring peritoneovenous (Denver) shunt placement in the setting of essential thrombocytosis (ET). Case Description/Methods: A 38-year-old woman with ET (JAK2 V617F mutation) presented to an outside hospital with acute onset abdominal distension occurring overnight. She denied fever, confusion, or yellowing of eyes. Examination showed a tense, distended abdomen with positive fluid wave, without scleral icterus or asterixis. Laboratory studies revealed alanine aminotransferase 675 U/L, aspartate aminotransferase 287 U/L, total bilirubin 0.5 mg/dL, albumin 3.1 g/dL, serum ascites albumin gradient >1.1, ascitic fluid protein <2.5 g/dl and international normalized ratio 1.3. Initial computed tomography (CT) indicated a non-cirrhotic liver with heterogeneous enhancement, marked ascites, and caudate lobe prominence, without clear evaluation of vascular patency. Viral, autoimmune, and cholestatic serologies were negative. Liver biopsy indicated severe hepatic congestion without fibrosis. Subsequent Magnetic Resonance Imaging showed extensive thrombosis involving hepatic veins, main and right PV, superior mesenteric vein, and proximal splenic vein occlusion. The patient began heparin anticoagulation therapy and was transferred to our center for PV recanalization. Interventional radiology (IR) attempted direct intrahepatic portocaval shunt placement, which failed due to extensive clot burden. The patient developed acute abdominal pain with worsening liver and renal function. Triple-phase CT demonstrated clot extension into the infrarenal inferior vena cava (IVC) and new left PV thrombosis. An emergent IVC thrombectomy was successful, with subsequent improvement of liver enzymes and renal function. Because of refractory ascites, PV recanalization was reattempted via transplenic and transhepatic access but was unsuccessful due to complete SVT. Due to persistent refractory ascites, a Denver shunt was placed by Hepatobiliary surgeon, leading to substantial improvement of ascites. Discussion: Extensive SVT combined with BCS is rare but can occur in hypercoagulable states, posing significant therapeutic challenges. While anticoagulation remains first-line treatment, rapid clot progression as seen in this patient highlights the importance of prompt multi-disciplinary interventions.

Authors

Publication Details

Journal
The American Journal of Gastroenterology
Published
2025-10-01
DOI
https://doi.org/10.14309/01.ajg.0001150120.86837.e4
Primary Topic
Liver Disease and Transplantation
Type
article
Field-Weighted Citation Impact
0.00
Controls
|||
ALL TIME
JAN
FEB
MAR
APR
MAY
JUN
JUL
AUG
SEP
OCT
article

S5665 Rapidly Progressive Splanchnic Thrombosis in Essential Thrombocytosis: When Anticoagulation Isn’t Enough

Aneeq Muhammad Yousuf, Namrata Paladugu, Colleen L. Moody, Joydeep Chakraborty
The American Journal of Gastroenterology
Liver Disease and Transplantation
article

S5665 Rapidly Progressive Splanchnic Thrombosis in Essential Thrombocytosis: When Anticoagulation Isn’t Enough

Aneeq Muhammad Yousuf, Namrata Paladugu, Colleen L. Moody, Joydeep Chakraborty
article en

Abstract

Introduction: Splanchnic venous thrombosis (SVT) includes thrombosis of splenic, mesenteric, portal, and hepatic veins. Portal (PV) and mesenteric veins are most commonly affected, whereas hepatic vein involvement, known as Budd-Chiari syndrome (BCS), is less common. We present a complex case of extensive SVT requiring peritoneovenous (Denver) shunt placement in the setting of essential thrombocytosis (ET). Case Description/Methods: A 38-year-old woman with ET (JAK2 V617F mutation) presented to an outside hospital with acute onset abdominal distension occurring overnight. She denied fever, confusion, or yellowing of eyes. Examination showed a tense, distended abdomen with positive fluid wave, without scleral icterus or asterixis. Laboratory studies revealed alanine aminotransferase 675 U/L, aspartate aminotransferase 287 U/L, total bilirubin 0.5 mg/dL, albumin 3.1 g/dL, serum ascites albumin gradient >1.1, ascitic fluid protein <2.5 g/dl and international normalized ratio 1.3. Initial computed tomography (CT) indicated a non-cirrhotic liver with heterogeneous enhancement, marked ascites, and caudate lobe prominence, without clear evaluation of vascular patency. Viral, autoimmune, and cholestatic serologies were negative. Liver biopsy indicated severe hepatic congestion without fibrosis. Subsequent Magnetic Resonance Imaging showed extensive thrombosis involving hepatic veins, main and right PV, superior mesenteric vein, and proximal splenic vein occlusion. The patient began heparin anticoagulation therapy and was transferred to our center for PV recanalization. Interventional radiology (IR) attempted direct intrahepatic portocaval shunt placement, which failed due to extensive clot burden. The patient developed acute abdominal pain with worsening liver and renal function. Triple-phase CT demonstrated clot extension into the infrarenal inferior vena cava (IVC) and new left PV thrombosis. An emergent IVC thrombectomy was successful, with subsequent improvement of liver enzymes and renal function. Because of refractory ascites, PV recanalization was reattempted via transplenic and transhepatic access but was unsuccessful due to complete SVT. Due to persistent refractory ascites, a Denver shunt was placed by Hepatobiliary surgeon, leading to substantial improvement of ascites. Discussion: Extensive SVT combined with BCS is rare but can occur in hypercoagulable states, posing significant therapeutic challenges. While anticoagulation remains first-line treatment, rapid clot progression as seen in this patient highlights the importance of prompt multi-disciplinary interventions.

The American Journal of GastroenterologyVol. 120(10S2)
Openalex Percentile: Top 48%
Liver Disease and Transplantation
AI Navigator

Ask Laika to Summarize, Analyze, and Connect papers live on the map.

Summarize Papers & Methodologies

Extract key findings, datasets, and comparative methods across publications.

Benchmark Rankings & Visual Analytics

Rank top research institutions, authors, funders, topics, and journals by Field-Weighted Citation Impact (FWCI) and paper volume with instant charts.

Connect Distant Disciplines

Bridge topological clusters on the map to find hidden collaborative intersections.